Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
Hepatitis B, Chronic
Pregnancy Complications, Infectious
Antiviral therapy improves HBV suppression and reduces MTCT in women with chronic HBV infection with high viral load compared to the use of hepatitis B immunoglobulin and vaccination alone; the use of telbivudine, lamivudine, and tenofovir appears to be safe in pregnancy with no increased adverse maternal or fetal outcome. (Hepatology 2016;63:319-333).